Sun Pharmaceutical Industries shares surge nearly 3% post Q2 results – Sun Pharma Q2 FY25 Results: Revenue grows 9% YoY to ₹13,291 crore, Net Profit jumps 27.5% YoY to ₹3,040 crore
Sun Pharmaceutical Industries Limited has reported strong Q2 FY25 financial results, showcasing significant year-over-year (YoY) growth in both revenue and net profit. The company’s continuous expansion across various markets, particularly in the United States, has driven its impressive financial performance.
Key Financial Highlights:
- Q2 FY25 Revenue: ₹13,291.39 crore (₹132,913.9 million)
- Q2 FY24 Revenue: ₹12,192.41 crore (₹121,924.1 million)
- YoY Revenue Growth: Approximately 9%
- Net Profit:
- Q2 FY25: ₹3,040.1 crore
- Q2 FY24: ₹2,375.5 crore
- YoY Growth: 27.5%
Quarter-on-Quarter (QoQ) Performance:
- Revenue increased from ₹12,524.5 crore in Q1 FY25 to ₹13,291.39 crore in Q2 FY25, showing a growth of 5.9%.
- Net Profit rose from ₹2,835.6 crore in Q1 FY25 to ₹3,040.1 crore in Q2 FY25, reflecting a 7.2% increase QoQ.
